• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

News

News you can use

Conferences

All the latest conference updates; those that we are attending and the studies that we are presenting

IASP

IASP

Transpharmation Ltd are delighted to be one of the sponsors of the first virtual conference held by The International Association for the Study of Pain, (IASP). The event runs from 8th September 2020 to 31st March 2021. We’ll be showcasing our latest specialist poster; ‘The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type 1 diabetic rodents’. Come and see us! #iaspvirtualseries https://www.eventscribe.com/2020/IASP-Virtual-Series-on-Pain/

 

 

 

 

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design